Home›People›Patrick Morris
PM

Patrick Morris

Executive Vice President and Secretary at Paragon Biosciences Emalex Capital. Also a director at Castle Creek Biosciences, a president, secretary and general counsel, director at CIRC Biosciences and an executive officer and director at Evozyne.

ExecutiveDirectorRoles at 4 startups
Updated Nov 9, 2026·Latest SEC filing Jul 8, 2025·Suggest an edit

About Patrick Morris

Patrick Morris is an executive vice president and secretary at Paragon Biosciences Emalex Capital.

Form D filings also name Patrick Morris as a director at Castle Creek Biosciences, a president, secretary and general counsel, director at CIRC Biosciences and an executive officer and director at Evozyne.

Patrick Morris first appears on SEC filings in 2018.

Experience

This experience comes from SEC filings. The years are when the filings name Patrick Morris in the role, so the role may have started earlier or lasted longer.

Paragon Biosciences Emalex Capital, Inc.
Executive Vice President and Secretary
2018 – 2025 · Chicaco, IL
Castle Creek Biosciences, Inc.
Director
2018 – 2025 · Exton, PA
CIRC Biosciences, Inc.
President, Secretary and General Counsel, director
2020 – 2024 · Chicago, IL
Evozyne, Inc.
Executive officer and director
2020 – 2023 · Chicago, IL

Key Colleagues at Startups

The people Patrick Morris works with at each company, as listed on that company's latest Form D.

JA
AG
EM
Eric Messner
Executive officer and director
RS
Ricky Sun
Director
JD
DP
Darien Parhad
Executive officer
Castle Creek Biosciences, Inc. · Form D, Feb 25, 2025
DB
David Brill
Director
JA
MG
Matthew Gantz
Executive officer and director
JS
Jude Sullivan
General Counsel and Assistant Secretary
DP
Darien Parhad
Executive officer
AG
CIRC Biosciences, Inc. · Form D, Oct 7, 2024
DP
Darien Parhad
Executive officer
TC
SC
Sai Chavala
Director
AG
JA
Evozyne, Inc. · Form D, Sep 29, 2023
AG
JA
Jeffrey Aronin
Chairman and Director
AT
Aris Theologis
Chief Business Officer
DP
Darien Parhad
Chief Financial Officer and Treasurer
JS
Jude Sullivan
General Counsel and Secretary
AL
Aleina Lee
Corporate Controller
RR
Rama Ranganathan
Chief Scientific Officer and Director
MG
Mike Gamson
President, Chief Executive Officer, and Director
MR
AR
Arjun Rallapalli
Chief Operating Officer

Sources

  1. SECParagon Biosciences Emalex Capital, Inc. Form D/A, filed Jul 8, 2025
  2. SECCastle Creek Biosciences, Inc. Form D, filed Feb 25, 2025
  3. SECCIRC Biosciences, Inc. Form D, filed Oct 7, 2024
  4. SECEvozyne, Inc. Form D, filed Sep 29, 2023